Hemosave Device

December 7, 2024 by CITE in Projects

Hemosave addresses the burden of Postpartum Hemorrhage, whichis the leading cause of maternal deaths globally accounting for70,000 deaths annually although this value increases to 60% inLMICs. In Uganda it is responsible for 127,000 deaths annually which accounts for 25% of all maternal deaths. PPH has such asignificant impact because blood loss during delivery is visually estimated by gynecologists rather than quantitatively measured,leading to inaccurate or delayed diagnosis.Hemosave device is a low cost device designed to prevent PPH by monitoring blood loss in real time during Cesarean section.

It is designed from locally available resources, offers a sustainable,low-cost solution at just $70 and user-centered crafted for LMICs.This early detection will allow doctors to give swift, appropriate treatment such as clotting drugs or transfusions to replenish lostblood, and hence save the mother’s life.

Founded by:Haasini Nandiyaala, James Bradley, Joel Mugabo, Samantha Keshara